FFCP PHASE2:Hg19::chr16:3627377..3627431,-
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p1@NLRC3 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_NLRC3_5end |
Coexpression cluster: | C57_Neutrophils_Eosinophils_Whole_CD4_CD8_CD19_Natural |
Association with transcript: | 0bp_to_ENST00000301749, ENST00000324659, ENST00000359128, ENST00000419350, ENST00000448023, NM_178844, uc010btn.2_5end |
EntrezGene: | NLRC3 |
HGNC: | 29889 |
UniProt: | Q7RTR2B5MDB6C9JLH9C3VPR7 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p1@NLRC3 |
---|
0
10
20
30
40
50
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
hematopoietic stem cell | 1.74e-48 | 168 |
hematopoietic cell | 8.72e-48 | 177 |
hematopoietic oligopotent progenitor cell | 7.56e-44 | 161 |
hematopoietic multipotent progenitor cell | 7.56e-44 | 161 |
lymphocyte | 2.37e-43 | 53 |
common lymphoid progenitor | 2.37e-43 | 53 |
lymphoid lineage restricted progenitor cell | 1.69e-42 | 52 |
leukocyte | 3.56e-32 | 136 |
nongranular leukocyte | 9.26e-27 | 115 |
T cell | 3.83e-26 | 25 |
Showing 1 to 10 of 26 entries
Ontology term | p-value | n |
---|---|---|
blood | 4.01e-16 | 15 |
haemolymphatic fluid | 4.01e-16 | 15 |
organism substance | 4.01e-16 | 15 |
hemolymphoid system | 4.49e-09 | 108 |
hematopoietic system | 1.42e-08 | 98 |
blood island | 1.42e-08 | 98 |
connective tissue | 4.70e-07 | 371 |
Showing 1 to 7 of 7 entries
Ontology term | p-value | n |
---|---|---|
hematologic cancer | 5.90e-21 | 51 |
immune system cancer | 5.90e-21 | 51 |
leukemia | 1.65e-20 | 39 |
myeloid leukemia | 1.64e-14 | 31 |
Showing 1 to 4 of 4 entries